Acuta Capital Partners, LLC Selecta Biosciences Inc Transaction History

Acuta Capital Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$2.89 - $4.43 $2.96 Million - $4.54 Million	-1,024,668 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$2.82 - $5.01 $568,703 - $1.01 Million	201,668 Added 24.5%	1,024,668 $4.28 Million
Q1 2021 May 17, 2021	BUY	$2.92 - $5.07 $2.4 Million - $4.17 Million	823,000 New	823,000 $3.72 Million
Q4 2020 Feb 16, 2021	SELL	$1.64 - $3.42 $3.88 Million - $8.09 Million	-2,364,204 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$1.32 - $2.47 $3.12 Million - $5.84 Million	2,364,204 New	2,364,204 $5.35 Million

4.67M

Ticker SELB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 152,712,992
Market Cap $128M
Description
Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...

Get notified when there are updates to the investment portfolio of Acuta Capital Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Acuta Capital Partners, LLC with notifications on news.